CULVER CITY, Calif., Sept. 12, 2019 /PRNewswire-PRWeb/ -- The World Molecular Imaging Society (WMIS) held its 2nd Imaging Shark Tank competition at the Annual World Molecular Imaging Congress (WMIC) at the Palais congrès de Montréal, hosted by Dr. Jack Hoppin, Co-Founder & Managing Partner of inviCRO. Double Helix Optics was chosen as the winner by a panel of life science investors and researchers:
- Damian Lamb, Managing Director at Genesys Capital,
- Sam Ifergan, Founder & CEO of iGan Partners,
- Thomas J. Meade, Ph.D, The Eileen M. Foell Professor of Cancer Research at Northwestern University and,
- Daniel Hetu, M.D., MBA Lumira Ventures
Double Helix was chosen as the winner because they showed a strong business model, addressed an unmet need and demonstrated an understanding of the current market dynamics.
"The world we live in is 3D and the world we have yet to discover is 3D. With our Light Engineering technology, scientists are now able to study cellular structures and inter and intra-cellular interactions in three dimensions and deep inside the cell. Our technology is already enabling new discoveries in a range of scientific fields from neuroscience to cancer. And we have only just begun," said Leslie Kimerling, co-founder and CEO of Double Helix Optics.
Double Helix Optics' patented Light Engineering™ technology is designed as an attachable modular upgrade to existing cameras and microscope systems and will enable scientists to visualize objects in 3D. By allowing a deeper layer of nanoscale visualization and data capture, from single molecule to whole cell, scientist will now have the opportunity to accelerate the pace of disease discovery and therapeutics development.
About Double Helix Optics
Double Helix Optics enables visualization and data capture of objects at an unmatched depth and precision quality. Our Light Engineering™ point spread function-based technology is advancing the field of 3D imaging, allowing for new discoveries in research and new capabilities of promise to a range of applications.
Discover more at doublehelixoptics.com.
About WMIS
The WMIS is dedicated to developing and promoting translational research through multimodality molecular imaging. The education and abstract-driven WMIC is the annual meeting of the WMIS and provides a unique setting for scientists and clinicians with very diverse backgrounds to interact, present, and follow cutting-edge advances in the rapidly expanding field of molecular imaging that impacts nearly every biomedical discipline. Industry exhibits at the congress included corporations who have created the latest advances in preclinical and clinical imaging approaches and equipment, providing a complete molecular imaging educational technology showcase. For more information: http://www.wmis.org
SOURCE WMIS
Share this article